326 related items for PubMed ID: 22495188
1. New treatment strategies in idiopathic nephrotic syndrome.
Ulinski T, Aoun B.
Minerva Pediatr; 2012 Apr; 64(2):135-43. PubMed ID: 22495188
[Abstract] [Full Text] [Related]
2. Pediatric idiopathic nephrotic syndrome: treatment strategies in steroid dependent and steroid resistant forms.
Ulinski T, Aoun B.
Curr Med Chem; 2010 Apr; 17(9):847-53. PubMed ID: 20156172
[Abstract] [Full Text] [Related]
3. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.
Przegl Lek; 2006 Apr; 63 Suppl 3():44-8. PubMed ID: 16898486
[Abstract] [Full Text] [Related]
4. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
Horinouchi T, Sako M, Nakanishi K, Ishikura K, Ito S, Nakamura H, Oba MS, Nozu K, Iijima K.
BMC Nephrol; 2018 Nov 01; 19(1):302. PubMed ID: 30382824
[Abstract] [Full Text] [Related]
5. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome.
Mendizábal S, Zamora I, Berbel O, Sanahuja MJ, Fuentes J, Simon J.
Pediatr Nephrol; 2005 Jul 01; 20(7):914-9. PubMed ID: 15891923
[Abstract] [Full Text] [Related]
6. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
Wu B, Mao J, Shen H, Fu H, Wang J, Liu A, Gu W, Shu Q, Du L.
Nephrology (Carlton); 2015 Jan 01; 20(1):18-24. PubMed ID: 25312783
[Abstract] [Full Text] [Related]
7. Cyclosporine versus mycophenolate mofetil for maintenance of remission of steroid-dependent nephrotic syndrome after a single infusion of rituximab.
Fujinaga S, Someya T, Watanabe T, Ito A, Ohtomo Y, Shimizu T, Kaneko K.
Eur J Pediatr; 2013 Apr 01; 172(4):513-8. PubMed ID: 23271494
[Abstract] [Full Text] [Related]
8. [Mycophenolate mofetil (MMF) as the first choice immunosuppressive drug in treatment of steroid-dependent nephrotic syndrome in children].
Ogarek I, Szczęsny-Choruz E, Wierzchowska-Słowiaczek E, Kwinta-Rybicka J, Stec Z, Moczulska A, Wilkosz K, Drożdż D.
Pol Merkur Lekarski; 2018 Apr 23; 44(262):192-195. PubMed ID: 29775447
[Abstract] [Full Text] [Related]
9. Switch from cyclosporine A to mycophenolate mofetil in nephrotic children.
Ulinski T, Dubourg L, Saïd MH, Parchoux B, Ranchin B, Cochat P.
Pediatr Nephrol; 2005 Apr 23; 20(4):482-5. PubMed ID: 15719253
[Abstract] [Full Text] [Related]
10. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
Kang Z, Li Z, Duan C, Wu T, Xun M, Ding Y, Zhang Y, Zhang L, Yin Y.
Pediatr Nephrol; 2015 Jul 23; 30(7):1121-9. PubMed ID: 25773534
[Abstract] [Full Text] [Related]
11. Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome.
Barletta GM, Smoyer WE, Bunchman TE, Flynn JT, Kershaw DB.
Pediatr Nephrol; 2003 Aug 23; 18(8):833-7. PubMed ID: 12774223
[Abstract] [Full Text] [Related]
12. Mycophenolate mofetil therapy for children with intractable nephrotic syndrome.
Okada M, Sugimoto K, Yagi K, Yanagida H, Tabata N, Takemura T.
Pediatr Int; 2007 Dec 23; 49(6):933-7. PubMed ID: 18045300
[Abstract] [Full Text] [Related]
13. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
Bagga A, Hari P, Moudgil A, Jordan SC.
Am J Kidney Dis; 2003 Dec 23; 42(6):1114-20. PubMed ID: 14655181
[Abstract] [Full Text] [Related]
14. New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome.
van Husen M, Kemper MJ.
Pediatr Nephrol; 2011 Jun 23; 26(6):881-92. PubMed ID: 21229269
[Abstract] [Full Text] [Related]
15. Evaluation and management of steroid-sensitive nephrotic syndrome.
Hodson EM, Alexander SI.
Curr Opin Pediatr; 2008 Apr 23; 20(2):145-50. PubMed ID: 18332709
[Abstract] [Full Text] [Related]
16. Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome.
Dehoux L, Hogan J, Dossier C, Fila M, Niel O, Maisin A, Macher MA, Kwon T, Baudouin V, Deschênes G.
Pediatr Nephrol; 2016 Nov 23; 31(11):2095-101. PubMed ID: 27263020
[Abstract] [Full Text] [Related]
17. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
Sinha A, Gupta A, Kalaivani M, Hari P, Dinda AK, Bagga A.
Kidney Int; 2017 Jul 23; 92(1):248-257. PubMed ID: 28318625
[Abstract] [Full Text] [Related]
18. Positive role of rituximab in switching from cyclosporine to mycophenolate mofetil for children with high-dose steroid-dependent nephrotic syndrome.
Fujinaga S, Sakuraya K, Yamada A, Urushihara Y, Ohtomo Y, Shimizu T.
Pediatr Nephrol; 2015 Apr 23; 30(4):687-91. PubMed ID: 25576066
[Abstract] [Full Text] [Related]
19. Mycophenolate mofetil for sustained remission in nephrotic syndrome.
Querfeld U, Weber LT.
Pediatr Nephrol; 2018 Dec 23; 33(12):2253-2265. PubMed ID: 29750317
[Abstract] [Full Text] [Related]
20. Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions.
Moudgil A, Bagga A, Jordan SC.
Pediatr Nephrol; 2005 Oct 23; 20(10):1376-81. PubMed ID: 15977023
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
